LDN Video Interviews and Presentations

Jane - Scotland: Ovarian Cancer (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Jane from Edinburgh takes Low Dose Naltrexone (LDN) for ovarian cancer. 

Jane's stomach started to swell up, making her look 9 months pregnant in 10 days, she was admitted to hospital where she was told she had a bad diet, but after being readmitted the following week, they took 13 litres of fluid from her stomach, where scans then showed she had ovarian cancer. 

After 6 weeks she started chemotherapy, where she had a bad reaction to the initial dosages. After finishing chemo in July, she started taking Low Dose Naltrexone (LDN), at first she started to have disturbed nights, but now taking it in the morning, she had no bad effects, her mood has improved and will continue taking it where she will continue a follow up next year.

This is a summary to listen to the entire interview by click the video link.

Dr Wai Liu, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Wai Liu is from St. George’s Hospital in London UK. He had just published a paper on how low dose naltrexone (LDN) can affect certain cancer cell lines in the laboratory that hopefully will drive clinical trials, then get approval for LDN as a treatment for cancer.

They took cells from patients with certain forms of cancer and compared the effects on the gene expression profiles by LDN, and conventional-dose naltrexone. Genes involved in cell cycling, the way cancer cells can grow, can be controlled in the way they proliferate. They showed LDN could target certain genes responsible for the cell cycle, and if that was exploited, they might get a handle on how cancer would grow. Indeed, they showed LDN does slow the growth of certain cancer cells via its effect on these particular proteins. As well, they found that because of the effects on the cell cycle, LDN increased the proteins that controlled the ability of a cell to undergo cell death, and increase cell killing in those cancer cells.

Furthermore, after administering LDN for a few days followed by no LDN for a recovery phase, they found continued cell killing, something bizarre to them, but similar to what happens with other drugs such as cannabinoids, or a couple other agents. In certain situations they saw LDN as having no effect on cancer cells, but during the recovery phase, there was a much improved level of cell killing.

They also used different schedules of chemotherapy alongside LDN, like gemcitabine, oxaliplatin, and something else like cyclophosphamide, as they are proven cytotoxic agents. They showed on a laboratory petri dish level, that when using both LDN and a number of cytotoxic agents, there was a much-increased level of proteins such as BAX, that regulate the ability of a cancer cell to undergo cell death. Understanding the profile of how drugs work lets you predict the best drugs to combine with the drug you’re testing. So for example, using a form of chemotherapy that requires BAX to be present and LDN results in cooperation between two different drugs.

Dr. Liu is not aware of doctors using this information clinically. There are many anecdotal reports of how LDN can help alleviate cancer symptoms or help with cancer treatment. More research is needed to show the benefits of LDN in cancer patients, and in combination with various chemotherapies or immunotherapies. LDN does things to cancer cells, and people are beginning to see the value in LDN. The more people hear and read about LDN, and with an increasing amount of scientific literature to support LDN as a cancer therapy, the better chance to attract funding for clinical trials.

Summary from Dr. Wai Liu, listen to the video for the show.

Keywords: LDN, low dose naltrexone, cancer, chemotherapy, immunotherapy

Any questions or comments you may have, please contact us. I look forward to hearing from you. 

Dr Thomas Cowan, LDN Radio Show 14 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Thomas Cowan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Thomas Cowan practices holistic medicine in San Francisco and prescribes Low Dose Naltrexone (LDN). He also has a new book called ‘Human Heart, Cosmic Heart’.

He first heard of LDN in 1992 from one of his patients with AIDS who requested it. This occurred again four years later, prompting Dr Cowan into researching LDN more thoroughly and learning about its many benefits in combating autoimmune diseases.

He says that LDN’s side effects are very uncommon and that in 95% of his autoimmune patients, he has prescribed LDN. Dr Cowan is a strong advocate of LDN.

This is a summary of Dr Thomas Cowan’s interview. Please listen to the rest of Dr Cowan’s interview by clicking on the video above.

Dr Thomas Cowan, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo

Dr Thomas Cowan shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Thomas Cowan first came across Low Dose Naltrexone (LDN) around 20 years ago when one of his close friends had incurable lymphoma. Having refused to continue on conventional treatment which had little to no effect on improving his health, he researched alternative treatments and came across LDN which drastically helped him to recover.

In the last decade of his career, Dr Cowan has predominantly treated patients with Ulcerative Colitis (UC) and Crohn’s Disease, finding that LDN can be successful in treating both diseases and providing great relief to his patients.

This is a summary of Dr Thomas Cowan’s interview. Please listen to the rest of Dr Cowan’s story by clicking on the video above.

Pharmacist Sahar Swidan, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Sahar Swidan shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Sahar Swidan has had a busy career, traveling extensively to educate while running her own Compounding Pharmacy. She has witnessed many successes with the use of Low Dose Naltrexone (LDN) and also ultra-Low Dose Naltrexone. 

She is a humanitarian and is writing a book on opioid-free pain medicine in an effort to educate more people on the many other optional treatments. Many experts will add chapters.

In this interview she provides an interesting insight into pain management and how LDN can be used in its treatment.

This is a summary of Dr Sahar Swidan’s interview. Please listen to the rest of Dr Swidan’s story by clicking on the video above.

Dr Ronald Hoffman, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Ronald Hoffman shares his Low Dose Naltrexone (LDN) experience on ehe LDN Radio Show with Linda Elsegood.

Dr Ronald Hoffman is the founder and medical director of the Hoffman Center, New York’s oldest complementary medicine center. He's also the host of ‘Health Talk’, America's longest running physician-hosted radio program.

Dr Hoffman first came across Low Dose Naltrexone (LDN) in the 1980s when faced with a HIV patient. At the time there was no conventional treatment, but new approaches were emerging at the time in New York, headed by Dr Bernard Bihari.

One of such pioneering approaches was the use of LDN as a medication to treat drug addiction while also having a positive effect on the body’s immune response. Fascinated by Dr Bihari’s findings, Dr Hoffman has been a strong advocate of LDN since.

This is a summary of Dr Ronald Hoffman’s interview. Please listen to the rest of Dr Hoffman’s story by clicking on the video above.

Dr Ronald Hoffman Interviews Linda Elsegood on LDN and The LDN Book (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood shares her Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) Story on the Intelligent Medicine Podcast with Donald Hoffman.

In 1969 at the age of 13, Linda had glandular fever (Epstein-Barr virus). She was seriously ill and away from school for six months. 

Late 1999 Linda’s mother had a serious heart attack and the trauma affected her badly. She was working full time, travelling two and a half hours every day and running the home. This excessive workload and stress began to take its toll on her health, and by May 2000 she had lost her balance, lost feeling in the left side of her face and her head, tongue and nose were numb with pins and needles.

In early December 2003 Linda started Low Dose Naltrexone (LDN), and the results were incredibly positive. By Christmas Linda was functioning again, and her liver tests were back to normal. She felt like herself again.

Linda founded the LDN Research Trust in May 2004. In this interview she says that it is the most exciting thing she has ever done. She is able to give many hours a week to the Trust, helping people to get LDN and trying to get it into clinical trials.

This is a summary of Linda Elsegood’s interview. Please listen to the rest of Linda’s story by clicking on the video above.

Dr Nasha Winters - Low Dose Naltrexone, Mistletoe, and Cancer 04 Aug 2021 LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Nasha Winters has utilized Mistletoe therapy since 2003 and does a great job of explaining it’s history and how it works to combat cancer. She is an authority in the area and certainly has great success with it. She explains how Low Dose Naltrexone can be used to enhance the effectiveness of Mistletoe by building up the autoimmune system when necessary.

Review Ken Bruce
Listen to the video for the full story.

Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Richard Nahas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Richard Nahas is an LDN prescriber from Ottawa in Canada specialising in Brain Function and Brain Health.Dr Richard Nahas practices in Ottawa, Canada at the Seekers Centre. 

He was an ER doctor for 5 years, and in 2004 was involved in dealing with the SARS outbreak. He traveled extensively to other countries to observe the varied medical systems. For the past 12 years he has specialized in brain function and brain health. 

He explains how he does functional brain assessments through QEEG tests combined with observations of other neuropathic complaints. He has used LDN for over ten years, and describes the various ways brain and nerve damage affects our health. 

This interview touches upon Chronic Regional Pain syndrome, Neuroplasticity and pain thresholds. He explains how pain is related to sleep disorders, inflammation, mood, injuries and other diseases.

This is a summary of Dr Nahas’ interview. Please listen to the rest of Dr Nahas’ story by clicking on the video above.

Dr Paul Anderson, LDN Radio Show 19 May 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Paul Anderson shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Paul Anderson started 40 years ago working in medical labs and eventually started up his own lab. Bored with this, he sold the business to go back to school and become an MD. 

He observed that most family practitioners don't have time to delve deeply into the more complicated and difficult illnesses like Cancer and autoimmune diseases. Thus he studied further to become a Naturopathic Doctor and started up his clinic. 

He learned about Low Dose Naltrexone (LDN) approximately 15 years ago and treats his patients with a synergetic approach. He finds that LDN is his first line of treatment, but it is accompanied by diet, exercise, and lifestyle changes. Vitamins, supplements and herbs are utilized as an important part of treatment.

This is a summary of Dr Paul Anderson’s interview. Please listen to the rest of Dr Anderson’s story by clicking on the video above.